Severe hyperprolactinemia during lurasidone treatment in a 16-year old girl with schizophrenia – a case report

1Schneider C, Taylor D, Zalsman G, Frangou S, Kyriakopoulos M. Antipsychotics use in children and adolescents: An on-going challenge in clinical practice. J Psychopharmacol. 2014;28(7):615-23. Schneider C Taylor D Zalsman G Frangou S Kyriakopoulos M Antipsychotics use in children and adolescents: An on-going challenge in clinical practice J Psychopharmacol 201428 7 615 2310.1177/026988111453359924902872Search in Google Scholar

2Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharmacol. 2012;32(3):309-16. Cohen D Bonnot O Bodeau N Consoli A Laurent C Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis J Clin Psychopharmacol 201232 3 309 1610.1097/JCP.0b013e318254925922544019Search in Google Scholar

3Pappagallo M, Silva R. The effect of atypical antipsychotic agents on prolactin levels in children and adolescents. J Child Adolesc Psychopharmacol. 2004;14(3):359-71. Pappagallo M Silva R The effect of atypical antipsychotic agents on prolactin levels in children and adolescents J Child Adolesc Psychopharmacol 200414 3 359 7110.1089/cap.2004.14.35915650493Search in Google Scholar

4Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Chaimani A, et al. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. Eur Neuropsychopharmacol. 2018;28(6):659-74. Krause M Zhu Y Huhn M Schneider-Thoma J Bighelli I Chaimani A et al Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis Eur Neuropsychopharmacol 201828 6 659 7410.1016/j.euroneuro.2018.03.00829802039Search in Google Scholar

5Agapoff JRt, Olson DJ, White S, Huynh V. Rapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone. J Clin Psychopharmacol. 2020;40(4):410-2. Agapoff JRt Olson DJ White S Huynh V Rapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone J Clin Psychopharmacol 202040 4 410 210.1097/JCP.000000000000123032555004Search in Google Scholar

6Montejo AL, Arango C, Bernardo M, Carrasco JL, Crespo-Facorro B, Cruz JJ, et al. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. Front Neuroendocrinol. 2017;45:25-34. Montejo AL Arango C Bernardo M Carrasco JL Crespo-Facorro B Cruz JJ et al Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics Front Neuroendocrinol 20174525 3410.1016/j.yfrne.2017.02.00328235557Search in Google Scholar